 |
|
|
|
|
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Buee L. on NEWS: Exploring Genome Fragmentation in Neurodegeneration, We all agree that DNA damage increases with aging. Many proteins described in neurodegenerative... 26 Feb 2013.
|
|
|
 |
|
|
Buee L. on PAPER: Troquier L. et al., 2012, Recommendation Only. 13 Feb 2012.
|
|
|
|
|
|
Buee L. on PAPER: Sultan A. et al., 2011, Recommendation Only. 13 Dec 2010.
|
|
|
|
|
|
Buee L. on PAPER: Zhang J. et al., 2010, It is clear that the role of Cdk5 in neuronal cell death is much more complex than previously... 29 Apr 2010.
|
|
|
|
|
|
Buee L, Schraen S. on NEWS: Stayin’ Alive—Huge Study Quickens Quest for Plasma AD Biomarker, First, we would like to thank Dr Kamali-Moghaddam for his comments. Regarding the methodology,... 13 Oct 2009.
|
|
|
|
|
|
Buee L. on NEWS: FDA Deems U.S. Alzhemed Trial Results Inconclusive, Since Alzhemed is a disease modifyer, the use of biomarkers by quantification of Abeta in CSF... 9 Sep 2007.
|
|
|
|
|
|
Buee L. on PAPER: Hamdane M. et al., 2006 May-Jun, Pin1 was always considered a cell cycle regulator. This article indicates that Pin1 is likely a... 31 May 2006.
|
|
|
|
|
|
Buee L. on PAPER: Smet C. et al., 2004, The NMR approach of studying tau protein is opening new perspectives in tau biology and... 16 Nov 2004.
|
|
|
|
|
|
Buee L. on NEWS: A Better Tau Trap? Viral Somatic Transfer of Mutant Tau in Rats, This article is mostly technical, and only preliminary data are shown. I realize this may sound... 5 Jan 2004.
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
